{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:59:50Z","timestamp":1792587590287,"version":"4.5.0"},"reference-count":232,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41579-024-01144-9","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T04:55:27Z","timestamp":1737089727000},"page":"385-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Norovirus replication, host interactions and vaccine advances"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-2071","authenticated-orcid":false,"given":"B. V. Venkataram","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasirekha","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Palzkill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4813-4249","authenticated-orcid":false,"given":"Mary K.","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142927","volume":"10","author":"SM Pires","year":"2015","unstructured":"Pires, S. M. et al. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. PLoS ONE 10, e0142927 (2015).","journal-title":"PLoS ONE"},{"key":"1144_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151219","volume":"11","author":"SM Bartsch","year":"2016","unstructured":"Bartsch, S. M., Lopman, B. A., Ozawa, S., Hall, A. J. & Lee, B. Y. Global economic burden of norovirus gastroenteritis. PLoS ONE 11, e0151219 (2016).","journal-title":"PLoS ONE"},{"key":"1144_CR3","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMra1207742","volume":"367","author":"K Bok","year":"2012","unstructured":"Bok, K. & Green, K. Y. Norovirus gastroenteritis in immunocompromised patients. N. Engl. J. Med. 367, 2126\u20132132 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1144_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1099\/vir.0.059634-0","volume":"95","author":"LG Thorne","year":"2014","unstructured":"Thorne, L. G. & Goodfellow, I. G. Norovirus gene expression and replication. J. Gen. Virol. 95, 278\u2013291 (2014).","journal-title":"J. Gen. Virol."},{"key":"1144_CR5","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00705-013-1708-5","volume":"158","author":"A Kroneman","year":"2013","unstructured":"Kroneman, A. et al. Proposal for a unified norovirus nomenclature and genotyping. Arch. Virol. 158, 2059\u20132068 (2013).","journal-title":"Arch. Virol."},{"key":"1144_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1099\/jgv.0.001318","volume":"100","author":"P Chhabra","year":"2019","unstructured":"Chhabra, P. et al. Updated classification of norovirus genogroups and genotypes. J. Gen. Virol. 100, 1393\u20131406 (2019).","journal-title":"J. Gen. Virol."},{"key":"1144_CR7","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3201\/eid2705.204756","volume":"27","author":"JL Cannon","year":"2021","unstructured":"Cannon, J. L. et al. Global trends in norovirus genotype distribution among children with acute gastroenteritis. Emerg. Infect. Dis. 27, 1438\u20131445 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"1144_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1473-3099(18)30059-8","volume":"18","author":"J van Beek","year":"2018","unstructured":"van Beek, J. et al. Molecular surveillance of norovirus, 2005\u201316: an epidemiological analysis of data collected from the NoroNet network. Lancet Infect. Dis. 18, 545\u2013553 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1086\/605127","volume":"200","author":"JJ Siebenga","year":"2009","unstructured":"Siebenga, J. J. et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001\u20132007. J. Infect. Dis. 200, 802\u2013812 (2009).","journal-title":"J. Infect. Dis."},{"key":"1144_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3201\/eid2308.161138","volume":"23","author":"MCW Chan","year":"2017","unstructured":"Chan, M. C. W. et al. Global spread of norovirus GII.17 Kawasaki 308, 2014\u20132016. Emerg. Infect. Dis. 23, 1359\u20131354 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"1144_CR11","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3201\/eid2311.170561","volume":"23","author":"K Kwok","year":"2017","unstructured":"Kwok, K. et al. Increased detection of emergent recombinant norovirus GII.P16-GII.2 strains in young adults, Hong Kong, China, 2016\u20132017. Emerg. Infect. Dis. 23, 1852\u20131855 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"1144_CR12","doi-asserted-by":"publisher","first-page":"2400625","DOI":"10.2807\/1560-7917.ES.2024.29.39.2400625","volume":"29","author":"P Chhabra","year":"2024","unstructured":"Chhabra, P. et al. Increased circulation of GII.17 noroviruses, six European countries and the United States, 2023 to 2024. Eur. Surveill. 29, 2400625 (2024).","journal-title":"Eur. Surveill."},{"key":"1144_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2354","volume":"32","author":"JA Kendra","year":"2022","unstructured":"Kendra, J. A., Tohma, K. & Parra, G. I. Global and regional circulation trends of norovirus genotypes and recombinants, 1995\u20132019: a comprehensive review of sequences from public databases. Rev. Med. Virol. 32, e2354 (2022).","journal-title":"Rev. Med. Virol."},{"key":"1144_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11262-010-0535-y","volume":"42","author":"RA Bull","year":"2011","unstructured":"Bull, R. A. et al. Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes. 42, 16\u201327 (2011).","journal-title":"Virus Genes."},{"key":"1144_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006136","volume":"13","author":"GI Parra","year":"2017","unstructured":"Parra, G. I. et al. Static and evolving norovirus genotypes: implications for epidemiology and Immunity. PLoS Pathog. 13, e1006136 (2017).","journal-title":"PLoS Pathog."},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3201\/eid3001.231003","volume":"30","author":"P Chhabra","year":"2024","unstructured":"Chhabra, P. et al. Emergence of novel norovirus GII.4 variant. Emerg. Infect. Dis. 30, 163\u2013167 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"00187","DOI":"10.1128\/mSphereDirect.00187-17","volume":"2","author":"K Tohma","year":"2017","unstructured":"Tohma, K., Lepore, C. J., Ford-Siltz, L. A. & Parra, G. I. Phylogenetic analyses suggest that factors other than the capsid protein play a role in the epidemic potential of GII.2 norovirus. mSphere 2, 00187-17 (2017).","journal-title":"mSphere"},{"key":"1144_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm860","volume":"9","author":"L Lindesmith","year":"2003","unstructured":"Lindesmith, L. et al. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548\u2013553 (2003).","journal-title":"Nat. Med."},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jmv.20423","volume":"77","author":"AM Hutson","year":"2005","unstructured":"Hutson, A. M., Airaud, F., LePendu, J., Estes, M. K. & Atmar, R. L. Norwalk virus infection associates with secretor status genotyped from sera. J. Med. Virol. 77, 116\u2013120 (2005).","journal-title":"J. Med. Virol."},{"key":"1144_CR20","doi-asserted-by":"publisher","first-page":"15351","DOI":"10.1128\/JVI.79.24.15351-15355.2005","volume":"79","author":"M Thorven","year":"2005","unstructured":"Thorven, M. et al. A homozygous nonsense mutation (428G\u2192A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79, 15351\u201315355 (2005).","journal-title":"J. Virol."},{"key":"1144_CR21","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1128\/JVI.02077-10","volume":"85","author":"A de Rougemont","year":"2011","unstructured":"de Rougemont, A. et al. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J. Virol. 85, 4057\u20134070 (2011).","journal-title":"J. Virol."},{"key":"1144_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009745","volume":"17","author":"Y Liang","year":"2021","unstructured":"Liang, Y. et al. Evolution of the interactions between GII.4 noroviruses and histo-blood group antigens: insights from experimental and computational studies. PLoS Pathog. 17, e1009745 (2021).","journal-title":"PLoS Pathog."},{"key":"1144_CR23","doi-asserted-by":"publisher","first-page":"858245","DOI":"10.3389\/fmicb.2022.858245","volume":"13","author":"M Estienney","year":"2022","unstructured":"Estienney, M. et al. Epidemiological impact of GII.17 human noroviruses associated with attachment to enterocytes. Front. Microbiol. 13, 858245 (2022).","journal-title":"Front. Microbiol."},{"key":"1144_CR24","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3390\/v13102066","volume":"13","author":"VR Tenge","year":"2021","unstructured":"Tenge, V. R. et al. Glycan recognition in human norovirus infections. Viruses 13, 2066 (2021).","journal-title":"Viruses"},{"key":"1144_CR25","doi-asserted-by":"publisher","first-page":"10372","DOI":"10.1128\/JVI.00809-06","volume":"80","author":"S Cheetham","year":"2006","unstructured":"Cheetham, S. et al. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J. Virol. 80, 10372\u201310381 (2006).","journal-title":"J. Virol."},{"key":"1144_CR26","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1128\/JVI.01347-07","volume":"82","author":"M Souza","year":"2008","unstructured":"Souza, M., Azevedo, M. S., Jung, K., Cheetham, S. & Saif, L. J. Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J. Virol. 82, 1777\u20131786 (2008).","journal-title":"J. Virol."},{"key":"1144_CR27","doi-asserted-by":"publisher","first-page":"00450","DOI":"10.1128\/mBio.00450-13","volume":"4","author":"S Taube","year":"2013","unstructured":"Taube, S. et al. A mouse model for human norovirus. mBio 4, 00450-13 (2013).","journal-title":"mBio"},{"key":"1144_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.antiviral.2016.05.011","volume":"132","author":"AO Kolawole","year":"2016","unstructured":"Kolawole, A. O., Rocha-Pereira, J., Elftman, M. D., Neyts, J. & Wobus, C. E. Inhibition of human norovirus by a viral polymerase inhibitor in the B cell culture system and in the mouse model. Antivir. Res. 132, 46\u201349 (2016).","journal-title":"Antivir. Res."},{"key":"1144_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008009","volume":"15","author":"J Van Dycke","year":"2019","unstructured":"Van Dycke, J. et al. A robust human norovirus replication model in zebrafish larvae. PLoS Pathog. 15, e1008009 (2019).","journal-title":"PLoS Pathog."},{"key":"1144_CR30","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/s41596-021-00499-0","volume":"16","author":"J Van Dycke","year":"2021","unstructured":"Van Dycke, J. et al. Infection of zebrafish larvae with human norovirus and evaluation of the in vivo efficacy of small-molecule inhibitors. Nat. Protoc. 16, 1830\u20131849 (2021).","journal-title":"Nat. Protoc."},{"key":"1144_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00115-23","volume":"89","author":"MTH Tan","year":"2023","unstructured":"Tan, M. T. H., Gong, Z. & Li, D. Use of zebrafish embryos to reproduce human norovirus and to evaluate human norovirus infectivity decay after UV treatment. Appl. Environ. Microbiol. 89, e0011523 (2023).","journal-title":"Appl. Environ. Microbiol."},{"key":"1144_CR32","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1111\/jam.15379","volume":"132","author":"MTH Tan","year":"2022","unstructured":"Tan, M. T. H. et al. The globally re-emerging norovirus GII.2 manifests higher heat resistance than norovirus GII.4 and Tulane virus. J. Appl. Microbiol. 132, 2441\u20132449 (2022).","journal-title":"J. Appl. Microbiol."},{"key":"1144_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0950-3528(90)90054-K","volume":"4","author":"WD Cubitt","year":"1990","unstructured":"Cubitt, W. D. Human, small round structured viruses, caliciviruses and astroviruses. Baillieres Clin. Gastroenterol. 4, 643\u2013656 (1990).","journal-title":"Baillieres Clin. Gastroenterol."},{"key":"1144_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jmv.20273","volume":"75","author":"BH Rockx","year":"2005","unstructured":"Rockx, B. H., Bogers, W. M., Heeney, J. L., van Amerongen, G. & Koopmans, M. P. Experimental norovirus infections in non-human primates. J. Med. Virol. 75, 313\u2013320 (2005).","journal-title":"J. Med. Virol."},{"key":"1144_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jmv.1890020203","volume":"2","author":"RG Wyatt","year":"1978","unstructured":"Wyatt, R. G. et al. Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J. Med. Virol. 2, 89\u201396 (1978).","journal-title":"J. Med. Virol."},{"key":"1144_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/jmv.2159","volume":"66","author":"DS Subekti","year":"2002","unstructured":"Subekti, D. S. et al. Experimental infection of Macaca nemestrina with a Toronto Norwalk-like virus of epidemic viral gastroenteritis. J. Med. Virol. 66, 400\u2013406 (2002).","journal-title":"J. Med. Virol."},{"key":"1144_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1073\/pnas.1014577107","volume":"108","author":"K Bok","year":"2011","unstructured":"Bok, K. et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc. Natl Acad. Sci. USA 108, 325\u2013330 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR38","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41564-023-01585-7","volume":"9","author":"I Rimkute","year":"2024","unstructured":"Rimkute, I. et al. A non-human primate model for human norovirus infection. Nat. Microbiol. 9, 776\u2013786 (2024).","journal-title":"Nat. Microbiol."},{"key":"1144_CR39","doi-asserted-by":"publisher","first-page":"21738","DOI":"10.1074\/jbc.M114.550657","volume":"289","author":"L Chung","year":"2014","unstructured":"Chung, L. et al. Norovirus translation requires an interaction between the C terminus of the genome-linked viral protein VPg and eukaryotic translation initiation factor 4G. J. Biol. Chem. 289, 21738\u201321750 (2014).","journal-title":"J. Biol. Chem."},{"key":"1144_CR40","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/emboj\/cdg251","volume":"22","author":"KF Daughenbaugh","year":"2003","unstructured":"Daughenbaugh, K. F., Fraser, C. S., Hershey, J. W. & Hardy, M. E. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. EMBO J. 22, 2852\u20132859 (2003).","journal-title":"EMBO J."},{"key":"1144_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coviro.2011.09.003","volume":"1","author":"I Goodfellow","year":"2011","unstructured":"Goodfellow, I. The genome-linked protein VPg of vertebrate viruses \u2014 a multifaceted protein. Curr. Opin. Virol. 1, 355\u2013362 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"1144_CR42","doi-asserted-by":"publisher","first-page":"9438","DOI":"10.1021\/acs.jmedchem.5b00762","volume":"58","author":"Y Kim","year":"2015","unstructured":"Kim, Y., Galasiti Kankanamalage, A. C., Chang, K. O. & Groutas, W. C. Recent advances in the discovery of norovirus therapeutics. J. Med. Chem. 58, 9438\u20139450 (2015).","journal-title":"J. Med. Chem."},{"key":"1144_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.coviro.2016.06.002","volume":"18","author":"BV Prasad","year":"2016","unstructured":"Prasad, B. V. et al. Antiviral targets of human noroviruses. Curr. Opin. Virol. 18, 117\u2013125 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"1144_CR44","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/v13102069","volume":"13","author":"B Zhao","year":"2021","unstructured":"Zhao, B. et al. Norovirus protease structure and antivirals development. Viruses 13, 2069 (2021).","journal-title":"Viruses"},{"key":"1144_CR45","doi-asserted-by":"publisher","unstructured":"Pham, S. et al. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.16.613336 (2024).","DOI":"10.1101\/2024.09.16.613336"},{"key":"1144_CR46","doi-asserted-by":"publisher","first-page":"eadp9333","DOI":"10.1126\/sciadv.adp9333","volume":"10","author":"S Kaundal","year":"2024","unstructured":"Kaundal, S. et al. RNA-dependent RNA polymerase of predominant human norovirus forms liquid-liquid phase condensates as viral replication factories. Sci. Adv. 10, eadp9333 (2024).","journal-title":"Sci. Adv."},{"key":"1144_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3389\/fimmu.2020.00961","volume":"11","author":"CP Campillay-Veliz","year":"2020","unstructured":"Campillay-Veliz, C. P. et al. Human norovirus proteins: implications in the replicative cycle, pathogenesis, and the host immune response. Front. Immunol. 11, 961 (2020).","journal-title":"Front. Immunol."},{"key":"1144_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1743-422X-9-181","volume":"9","author":"TM Sharp","year":"2012","unstructured":"Sharp, T. M. et al. Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses. Virol. J. 9, 181 (2012).","journal-title":"Virol. J."},{"key":"1144_CR49","doi-asserted-by":"publisher","first-page":"e01606","DOI":"10.1128\/JVI.01606-17","volume":"92","author":"TF Li","year":"2018","unstructured":"Li, T. F. et al. Human norovirus NS3 has RNA helicase and chaperoning activities. J. Virol. 92, e01606-17 (2018).","journal-title":"J. Virol."},{"key":"1144_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006705","volume":"13","author":"SY Doerflinger","year":"2017","unstructured":"Doerflinger, S. Y. et al. Membrane alterations induced by nonstructural proteins of human norovirus. PLoS Pathog. 13, e1006705 (2017).","journal-title":"PLoS Pathog."},{"key":"1144_CR51","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00422-21","volume":"9","author":"JB Yen","year":"2021","unstructured":"Yen, J. B. et al. Identification and characterization of human norovirus NTPase regions required for lipid droplet localization, cellular apoptosis, and interaction with the viral P22 protein. Microbiol. Spectr. 9, e0042221 (2021).","journal-title":"Microbiol. Spectr."},{"key":"1144_CR52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.7326\/0003-4819-76-6-993","volume":"76","author":"NR Blacklow","year":"1972","unstructured":"Blacklow, N. R. et al. Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. Ann. Intern. Med. 76, 993\u20131008 (1972).","journal-title":"Ann. Intern. Med."},{"key":"1144_CR53","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.1086\/315584","volume":"181","author":"AZ Kapikian","year":"2000","unstructured":"Kapikian, A. Z. The discovery of the 27-nm Norwalk virus: an historic perspective. J. Infect. Dis. 181, S295\u2013S302 (2000).","journal-title":"J. Infect. Dis."},{"key":"1144_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1099\/vir.0.19478-0","volume":"85","author":"E Duizer","year":"2004","unstructured":"Duizer, E. et al. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85, 79\u201387 (2004).","journal-title":"J. Gen. Virol."},{"key":"1144_CR55","doi-asserted-by":"publisher","first-page":"12238","DOI":"10.1128\/JVI.01489-07","volume":"81","author":"S Guix","year":"2007","unstructured":"Guix, S. et al. Norwalk virus RNA is infectious in mammalian cells. J. Virol. 81, 12238\u201312248 (2007).","journal-title":"J. Virol."},{"key":"1144_CR56","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJM197306212882503","volume":"288","author":"DS Schreiber","year":"1973","unstructured":"Schreiber, D. S., Blacklow, N. R. & Trier, J. S. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N. Engl. J. Med. 288, 1318\u20131323 (1973).","journal-title":"N. Engl. J. Med."},{"key":"1144_CR57","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0002-9343(75)90461-1","volume":"59","author":"R Dolin","year":"1975","unstructured":"Dolin, R., Levy, A. G., Wyatt, R. G., Thornhill, T. S. & Gardner, J. D. Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am. J. Med. 59, 761\u2013768 (1975).","journal-title":"Am. J. Med."},{"key":"1144_CR58","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1099\/jgv.0.000545","volume":"97","author":"UC Karandikar","year":"2016","unstructured":"Karandikar, U. C. et al. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J. Gen. Virol. 97, 2291\u20132300 (2016).","journal-title":"J. Gen. Virol."},{"key":"1144_CR59","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/v11070638","volume":"11","author":"MK Estes","year":"2019","unstructured":"Estes, M. K. et al. Human norovirus cultivation in nontransformed stem cell-derived human intestinal enteroid cultures: success and challenges. Viruses 11, 638 (2019).","journal-title":"Viruses"},{"key":"1144_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16491-3","volume":"11","author":"KY Green","year":"2020","unstructured":"Green, K. Y. et al. Human norovirus targets enteroendocrine epithelial cells in the small intestine. Nat. Commun. 11, 2759 (2020).","journal-title":"Nat. Commun."},{"key":"1144_CR61","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1126\/science.1257147","volume":"346","author":"MK Jones","year":"2014","unstructured":"Jones, M. K. et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346, 755\u2013759 (2014).","journal-title":"Science"},{"key":"1144_CR62","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1038\/nprot.2015.121","volume":"10","author":"MK Jones","year":"2015","unstructured":"Jones, M. K. et al. Human norovirus culture in B cells. Nat. Protoc. 10, 1939\u20131947 (2015).","journal-title":"Nat. Protoc."},{"key":"1144_CR63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1126\/science.aar3799","volume":"360","author":"CB Wilen","year":"2018","unstructured":"Wilen, C. B. et al. Tropism for tuft cells determines immune promotion of norovirus pathogenesis. Science 360, 204\u2013208 (2018).","journal-title":"Science"},{"key":"1144_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00175-22","volume":"13","author":"C Mirabelli","year":"2022","unstructured":"Mirabelli, C. et al. Human norovirus triggers primary B cell immune activation in vitro. mBio 13, e0017522 (2022).","journal-title":"mBio"},{"key":"1144_CR65","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/cid\/ciw060","volume":"62","author":"JR Brown","year":"2016","unstructured":"Brown, J. R., Gilmour, K. & Breuer, J. Norovirus infections occur in B-cell-deficient patients. Clin. Infect. Dis. 62, 1136\u20131138 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"1144_CR66","doi-asserted-by":"publisher","first-page":"e01010","DOI":"10.1128\/JVI.01010-17","volume":"92","author":"CE Wobus","year":"2018","unstructured":"Wobus, C. E. The dual tropism of noroviruses. J. Virol. 92, e01010-17 (2018).","journal-title":"J. Virol."},{"key":"1144_CR67","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/v11060547","volume":"11","author":"S Bhar","year":"2019","unstructured":"Bhar, S. & Jones, M. K. In vitro replication of human norovirus. Viruses 11, 547 (2019).","journal-title":"Viruses"},{"key":"1144_CR68","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"1144_CR69","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aaf5211","volume":"353","author":"K Ettayebi","year":"2016","unstructured":"Ettayebi, K. et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 353, 1387\u20131393 (2016).","journal-title":"Science"},{"key":"1144_CR70","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1234852","volume":"340","author":"T Sato","year":"2013","unstructured":"Sato, T. & Clevers, H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190\u20131194 (2013).","journal-title":"Science"},{"key":"1144_CR71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/7651_2017_1","volume":"1576","author":"WY Zou","year":"2017","unstructured":"Zou, W. Y. et al. Human intestinal enteroids: new models to study gastrointestinal virus infections. Methods Mol. Biol. 1576, 229\u2013247 (2017).","journal-title":"Methods Mol. Biol."},{"key":"1144_CR72","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1073\/pnas.1910138117","volume":"117","author":"K Murakami","year":"2020","unstructured":"Murakami, K. et al. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc. Natl Acad. Sci. USA 117, 1700\u20131710 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR73","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/infdis\/jit620","volume":"209","author":"RL Atmar","year":"2014","unstructured":"Atmar, R. L. et al. Determination of the 50% human infectious dose for Norwalk virus. J. Infect. Dis. 209, 1016\u20131022 (2014).","journal-title":"J. Infect. Dis."},{"key":"1144_CR74","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/infdis\/jiac045","volume":"226","author":"N Rouphael","year":"2022","unstructured":"Rouphael, N. et al. Dose-response of a norovirus GII.2 controlled human challenge model inoculum. J. Infect. Dis. 226, 1771\u20131780 (2022).","journal-title":"J. Infect. Dis."},{"key":"1144_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01316-24","volume":"15","author":"GO Adeniyi-Ipadeola","year":"2024","unstructured":"Adeniyi-Ipadeola, G. O. et al. Infant and adult human intestinal enteroids are morphologically and functionally distinct. mBio 15, e0131624 (2024).","journal-title":"mBio"},{"key":"1144_CR76","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00636-23","volume":"67","author":"MA Lewis","year":"2023","unstructured":"Lewis, M. A. et al. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob. Agents Chemother. 67, e0063623 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1144_CR77","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00448-24","volume":"9","author":"K Ettayebi","year":"2024","unstructured":"Ettayebi, K. et al. Insights into human norovirus cultivation in human intestinal enteroids. mSphere 9, e0044824 (2024).","journal-title":"mSphere"},{"key":"1144_CR78","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3201\/eid2408.180126","volume":"24","author":"V Costantini","year":"2018","unstructured":"Costantini, V. et al. Human norovirus replication in human intestinal enteroids as a model to evaluate virus inactivation. Emerg. Infect. Dis. 24, 1453\u20131464 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"1144_CR79","doi-asserted-by":"publisher","first-page":"e01136","DOI":"10.1128\/mSphere.01136-20","volume":"6","author":"K Ettayebi","year":"2021","unstructured":"Ettayebi, K. et al. New insights and enhanced human norovirus cultivation in human intestinal enteroids. mSphere 6, e01136-20 (2021).","journal-title":"mSphere"},{"key":"1144_CR80","doi-asserted-by":"publisher","first-page":"121481","DOI":"10.1016\/j.watres.2024.121481","volume":"255","author":"N Carmona-Vicente","year":"2024","unstructured":"Carmona-Vicente, N. et al. Human intestinal enteroids platform to assess the infectivity of gastroenteritis viruses in wastewater. Water Res. 255, 121481 (2024).","journal-title":"Water Res."},{"key":"1144_CR81","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jcmgh.2019.04.010","volume":"8","author":"AL Chang-Graham","year":"2019","unstructured":"Chang-Graham, A. L. et al. Human intestinal enteroids with inducible neurogenin-3 expression as a novel model of ut hormone secretion. Cell Mol. Gastroenterol. Hepatol. 8, 209\u2013229 (2019).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1144_CR82","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09691","volume":"470","author":"JR Spence","year":"2011","unstructured":"Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105\u2013109 (2011).","journal-title":"Nature"},{"key":"1144_CR83","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/nprot.2011.410","volume":"6","author":"KW McCracken","year":"2011","unstructured":"McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920\u20131928 (2011).","journal-title":"Nat. Protoc."},{"key":"1144_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12736-2","volume":"7","author":"D Zhang","year":"2017","unstructured":"Zhang, D. et al. Human intestinal organoids express histo-blood group antigens, bind norovirus VLPs, and support limited norovirus replication. Sci. Rep. 7, 12621 (2017).","journal-title":"Sci. Rep."},{"key":"1144_CR85","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jcmgh.2018.11.001","volume":"7","author":"S Sato","year":"2019","unstructured":"Sato, S. et al. Human norovirus propagation in human induced pluripotent stem cell-derived intestinal epithelial cells. Cell. Mol. Gastroenterol. Hepatol. 7, 686\u2013688 (2019).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"1144_CR86","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/nm.3737","volume":"20","author":"CL Watson","year":"2014","unstructured":"Watson, C. L. et al. An in vivo model of human small intestine using pluripotent stem cells. Nat. Med. 20, 1310\u20131314 (2014).","journal-title":"Nat. Med."},{"key":"1144_CR87","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1242\/bio.013235","volume":"4","author":"SR Finkbeiner","year":"2015","unstructured":"Finkbeiner, S. R. et al. Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids. Biol. Open 4, 1462\u20131472 (2015).","journal-title":"Biol. Open"},{"key":"1144_CR88","doi-asserted-by":"publisher","first-page":"e00251","DOI":"10.1128\/mBio.00251-20","volume":"11","author":"K Haga","year":"2020","unstructured":"Haga, K. et al. Genetic manipulation of human intestinal enteroids demonstrates the necessity of a functional fucosyltransferase 2 gene for secretor-dependent human norovirus infection. mBio 11, e00251-20 (2020).","journal-title":"mBio"},{"key":"1144_CR89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/infdis\/jiu054","volume":"210","author":"N Ruvoen-Clouet","year":"2014","unstructured":"Ruvoen-Clouet, N. et al. Increase in genogroup II.4 norovirus host spectrum by CagA-positive Helicobacter pylori infection. J. Infect. Dis. 210, 183\u2013191 (2014).","journal-title":"J. Infect. Dis."},{"key":"1144_CR90","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1152\/physiolgenomics.00061.2021","volume":"53","author":"ZK Criss II","year":"2021","unstructured":"Criss, Z. K. II et al. Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol. Genomics 53, 486\u2013508 (2021).","journal-title":"Physiol. Genomics"},{"key":"1144_CR91","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/v13060998","volume":"13","author":"VR Tenge","year":"2021","unstructured":"Tenge, V. R. et al. Bile goes viral. Viruses 13, 998 (2021).","journal-title":"Viruses"},{"key":"1144_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02020-23","volume":"98","author":"V Tenge","year":"2024","unstructured":"Tenge, V. et al. Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. J. Virol. 98, e0202023 (2024).","journal-title":"J. Virol."},{"key":"1144_CR93","doi-asserted-by":"publisher","first-page":"e01581","DOI":"10.1128\/JVI.01581-18","volume":"93","author":"T Kilic","year":"2019","unstructured":"Kilic, T., Koromyslova, A. & Hansman, G. S. Structural basis for human norovirus capsid binding to bile acids. J. Virol. 93, e01581-18 (2019).","journal-title":"J. Virol."},{"key":"1144_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36398-z","volume":"14","author":"BV Ayyar","year":"2023","unstructured":"Ayyar, B. V. et al. CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat. Commun. 14, 1148 (2023).","journal-title":"Nat. Commun."},{"key":"1144_CR95","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s42003-021-01693-2","volume":"4","author":"A Ivashenka","year":"2021","unstructured":"Ivashenka, A. et al. Glycolipid-dependent and lectin-driven transcytosis in mouse enterocytes. Commun. Biol. 4, 173 (2021).","journal-title":"Commun. Biol."},{"key":"1144_CR96","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.bbamem.2013.03.016","volume":"1828","author":"GE Rydell","year":"2013","unstructured":"Rydell, G. E., Svensson, L., Larson, G., Johannes, L. & Romer, W. Human GII.4 norovirus VLP induces membrane invaginations on giant unilamellar vesicles containing secretor gene dependent \u03b11,2-fucosylated glycosphingolipids. Biochim. Biophys. Acta 1828, 1840\u20131845 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"1144_CR97","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","volume":"43","author":"S Koyama","year":"2008","unstructured":"Koyama, S., Ishii, K. J., Coban, C. & Akira, S. Innate immune response to viral infection. Cytokine 43, 336\u2013341 (2008).","journal-title":"Cytokine"},{"key":"1144_CR98","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nature12862","volume":"505","author":"JW Schoggins","year":"2014","unstructured":"Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691\u2013695 (2014).","journal-title":"Nature"},{"key":"1144_CR99","doi-asserted-by":"publisher","first-page":"23782","DOI":"10.1073\/pnas.2010834117","volume":"117","author":"SC Lin","year":"2020","unstructured":"Lin, S. C. et al. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc. Natl Acad. Sci. USA 117, 23782\u201323793 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR100","doi-asserted-by":"publisher","first-page":"e00215","DOI":"10.1128\/mBio.00215-20","volume":"11","author":"M Hosmillo","year":"2020","unstructured":"Hosmillo, M. et al. Norovirus replication in human intestinal epithelial cells is restricted by the interferon-induced JAK\/STAT signaling pathway and RNA polymerase II-mediated transcriptional responses. mBio 11, e00215-20 (2020).","journal-title":"mBio"},{"key":"1144_CR101","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1128\/jvi.66.11.6527-6532.1992","volume":"66","author":"X Jiang","year":"1992","unstructured":"Jiang, X., Wang, M., Graham, D. Y. & Estes, M. K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66, 6527\u20136532 (1992).","journal-title":"J. Virol."},{"key":"1144_CR102","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1126\/science.286.5438.287","volume":"286","author":"BV Prasad","year":"1999","unstructured":"Prasad, B. V. et al. X-ray crystallographic structure of the Norwalk virus capsid. Science 286, 287\u2013290 (1999).","journal-title":"Science"},{"key":"1144_CR103","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-018-0852-1","volume":"565","author":"MJ Conley","year":"2019","unstructured":"Conley, M. J. et al. Calicivirus VP2 forms a portal-like assembly following receptor engagement. Nature 565, 377\u2013381 (2019).","journal-title":"Nature"},{"key":"1144_CR104","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1128\/JVI.02371-09","volume":"84","author":"RJ Ossiboff","year":"2010","unstructured":"Ossiboff, R. J., Zhou, Y., Lightfoot, P. J., Prasad, B. V. & Parker, J. S. Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor. J. Virol. 84, 5550\u20135564 (2010).","journal-title":"J. Virol."},{"key":"1144_CR105","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1073\/pnas.0600421103","volume":"103","author":"R Chen","year":"2006","unstructured":"Chen, R., Neill, J. D., Estes, M. K. & Prasad, B. V. V. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc. Natl Acad. Sci. USA 103, 8048\u20138053 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR106","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01471-21","volume":"95","author":"AN Williams","year":"2021","unstructured":"Williams, A. N. et al. Multiple signals in the gut contract the mouse norovirus capsid to block antibody binding while enhancing receptor affinity. J. Virol. 95, e0147121 (2021).","journal-title":"J. Virol."},{"key":"1144_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008619","volume":"16","author":"C Song","year":"2020","unstructured":"Song, C. et al. Dynamic rotation of the protruding domain enhances the infectivity of norovirus. PLoS Pathog. 16, e1008619 (2020).","journal-title":"PLoS Pathog."},{"key":"1144_CR108","doi-asserted-by":"publisher","first-page":"e00970","DOI":"10.1128\/JVI.00970-19","volume":"93","author":"MB Sherman","year":"2019","unstructured":"Sherman, M. B. et al. Bile salts alter the mouse norovirus capsid conformation: possible implications for cell attachment and immune evasion. J. Virol. 93, e00970-19 (2019).","journal-title":"J. Virol."},{"key":"1144_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28757-z","volume":"13","author":"L Hu","year":"2022","unstructured":"Hu, L. et al. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity. Nat. Commun. 13, 1241 (2022).","journal-title":"Nat. Commun."},{"key":"1144_CR110","doi-asserted-by":"publisher","first-page":"11381","DOI":"10.1128\/JVI.05621-11","volume":"85","author":"D Bhella","year":"2011","unstructured":"Bhella, D. & Goodfellow, I. G. The cryo-electron microscopy structure of feline calicivirus bound to junctional adhesion molecule A at 9-angstrom resolution reveals receptor-induced flexibility and two distinct conformational changes in the capsid protein VP1. J. Virol. 85, 11381\u201311390 (2011).","journal-title":"J. Virol."},{"key":"1144_CR111","doi-asserted-by":"publisher","first-page":"E9201","DOI":"10.1073\/pnas.1805797115","volume":"115","author":"CA Nelson","year":"2018","unstructured":"Nelson, C. A. et al. Structural basis for murine norovirus engagement of bile acids and the CD300lf receptor. Proc. Natl Acad. Sci. USA 115, E9201\u2013E9210 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR112","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/v11030235","volume":"11","author":"HQ Smith","year":"2019","unstructured":"Smith, H. Q. & Smith, T. J. The dynamic capsid structures of the noroviruses. Viruses 11, 235 (2019).","journal-title":"Viruses"},{"key":"1144_CR113","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.coviro.2014.05.008","volume":"7","author":"BV Venkataram Prasad","year":"2014","unstructured":"Venkataram Prasad, B. V. et al. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr. Opin. Virol. 7, 119\u2013127 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"1144_CR114","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1128\/JVI.77.9.5266-5274.2003","volume":"77","author":"P Danthi","year":"2003","unstructured":"Danthi, P., Tosteson, M., Li, Q. H. & Chow, M. Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus. J. Virol. 77, 5266\u20135274 (2003).","journal-title":"J. Virol."},{"key":"1144_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008920","volume":"16","author":"PNM Shah","year":"2020","unstructured":"Shah, P. N. M. et al. Cryo-EM structures reveal two distinct conformational states in a picornavirus cell entry intermediate. PLoS Pathog. 16, e1008920 (2020).","journal-title":"PLoS Pathog."},{"key":"1144_CR116","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1128\/JVI.03508-12","volume":"87","author":"S Vongpunsawad","year":"2013","unstructured":"Vongpunsawad, S., Venkataram Prasad, B. V. & Estes, M. K. Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain. J. Virol. 87, 4818\u20134825 (2013).","journal-title":"J. Virol."},{"key":"1144_CR117","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/JVI.76.8.4044-4055.2002","volume":"76","author":"A Bertolotti-Ciarlet","year":"2002","unstructured":"Bertolotti-Ciarlet, A., White, L. J., Chen, R., Prasad, B. V. & Estes, M. K. Structural requirements for the assembly of Norwalk virus-like particles. J. Virol. 76, 4044\u20134055 (2002).","journal-title":"J. Virol."},{"key":"1144_CR118","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1128\/JVI.00219-07","volume":"81","author":"S Cao","year":"2007","unstructured":"Cao, S. et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81, 5949\u20135957 (2007).","journal-title":"J. Virol."},{"key":"1144_CR119","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.1073\/pnas.0803275105","volume":"105","author":"JM Choi","year":"2008","unstructured":"Choi, J. M., Hutson, A. M., Estes, M. K. & Prasad, B. V. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl Acad. Sci. USA 105, 9175\u20139180 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR120","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1128\/JVI.00201-14","volume":"88","author":"S Shanker","year":"2014","unstructured":"Shanker, S. et al. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses. J. Virol. 88, 6168\u20136180 (2014).","journal-title":"J. Virol."},{"key":"1144_CR121","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.sbi.2017.05.007","volume":"44","author":"S Shanker","year":"2017","unstructured":"Shanker, S. et al. Structural features of glycan recognition among viral pathogens. Curr. Opin. Struct. Biol. 44, 211\u2013218 (2017).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1144_CR122","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1128\/JVI.02968-14","volume":"89","author":"BK Singh","year":"2015","unstructured":"Singh, B. K., Leuthold, M. M. & Hansman, G. S. Human noroviruses\u2019 fondness for histo-blood group antigens. J. Virol. 89, 2024\u20132040 (2015).","journal-title":"J. Virol."},{"key":"1144_CR123","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tim.2011.05.007","volume":"19","author":"M Tan","year":"2011","unstructured":"Tan, M. & Jiang, X. Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol. 19, 382\u2013388 (2011).","journal-title":"Trends Microbiol."},{"key":"1144_CR124","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1053\/gast.2002.33661","volume":"122","author":"S Marionneau","year":"2002","unstructured":"Marionneau, S. et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122, 1967\u20131977 (2002).","journal-title":"Gastroenterology"},{"key":"1144_CR125","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1128\/JVI.00848-11","volume":"85","author":"S Shanker","year":"2011","unstructured":"Shanker, S. et al. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J. Virol. 85, 8635\u20138645 (2011).","journal-title":"J. Virol."},{"key":"1144_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050031","volume":"5","author":"LC Lindesmith","year":"2008","unstructured":"Lindesmith, L. C. et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5, e31 (2008).","journal-title":"PLoS Med."},{"key":"1144_CR127","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01716-22","volume":"97","author":"GI Parra","year":"2023","unstructured":"Parra, G. I. et al. Minimal antigenic evolution after a decade of norovirus GII.4 Sydney_2012 circulation in humans. J. Virol. 97, e0171622 (2023).","journal-title":"J. Virol."},{"key":"1144_CR128","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01861-22","volume":"13","author":"LC Lindesmith","year":"2022","unstructured":"Lindesmith, L. C. et al. Immune imprinting drives human norovirus potential for global spread. mBio 13, e0186122 (2022).","journal-title":"mBio"},{"key":"1144_CR129","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1128\/JVI.02200-07","volume":"82","author":"U Katpally","year":"2008","unstructured":"Katpally, U., Wobus, C. E., Dryden, K., Virgin, H. W. T. & Smith, T. J. Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles. J. Virol. 82, 2079\u20132088 (2008).","journal-title":"J. Virol."},{"key":"1144_CR130","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1128\/JVI.00314-10","volume":"84","author":"U Katpally","year":"2010","unstructured":"Katpally, U. et al. High-resolution cryo-electron microscopy structures of murine norovirus 1 and rabbit hemorrhagic disease virus reveal marked flexibility in the receptor binding domains. J. Virol. 84, 5836\u20135841 (2010).","journal-title":"J. Virol."},{"key":"1144_CR131","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01735-23","volume":"98","author":"M Sherman","year":"2024","unstructured":"Sherman, M. et al. The reversible activation of norovirus by metal ions. J. Virol. 98, e0173523 (2024).","journal-title":"J. Virol."},{"key":"1144_CR132","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virol.2020.10.005","volume":"553","author":"JM Devant","year":"2021","unstructured":"Devant, J. M. & Hansman, G. S. Structural heterogeneity of a human norovirus vaccine candidate. Virology 553, 23\u201334 (2021).","journal-title":"Virology"},{"key":"1144_CR133","doi-asserted-by":"publisher","first-page":"12828","DOI":"10.1073\/pnas.1903562116","volume":"116","author":"J Jung","year":"2019","unstructured":"Jung, J. et al. High-resolution cryo-EM structures of outbreak strain human norovirus shells reveal size variations. Proc. Natl Acad. Sci. USA 116, 12828\u201312832 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR134","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.antiviral.2019.05.010","volume":"168","author":"JM Devant","year":"2019","unstructured":"Devant, J. M., Hofhaus, G., Bhella, D. & Hansman, G. S. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T\u2009=\u20094 virus-like particles. Antivir. Res. 168, 175\u2013182 (2019).","journal-title":"Antivir. Res."},{"key":"1144_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42146-0","volume":"14","author":"W Salmen","year":"2023","unstructured":"Salmen, W. et al. A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity. Nat. Commun. 14, 6516 (2023).","journal-title":"Nat. Commun."},{"key":"1144_CR136","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","volume":"23","author":"DR Burton","year":"2023","unstructured":"Burton, D. R. Antiviral neutralizing antibodies: from in vitro to in vivo activity. Nat. Rev. Immunol. 23, 720\u2013734 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1144_CR137","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00705-006-0923-8","volume":"152","author":"SA Reading","year":"2007","unstructured":"Reading, S. A. & Dimmock, N. J. Neutralization of animal virus infectivity by antibody. Arch. Virol. 152, 1047\u20131059 (2007).","journal-title":"Arch. Virol."},{"key":"1144_CR138","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/v13030360","volume":"13","author":"L Touabi","year":"2021","unstructured":"Touabi, L., Aflatouni, F. & McLean, G. R. Mechanisms of rhinovirus neutralisation by antibodies. Viruses 13, 360 (2021).","journal-title":"Viruses"},{"key":"1144_CR139","doi-asserted-by":"publisher","first-page":"110689","DOI":"10.1016\/j.celrep.2022.110689","volume":"39","author":"K Tohma","year":"2022","unstructured":"Tohma, K., Ford-Siltz, L. A., Kendra, J. A. & Parra, G. I. Dynamic immunodominance hierarchy of neutralizing antibody responses to evolving GII.4 noroviruses. Cell Rep. 39, 110689 (2022).","journal-title":"Cell Rep."},{"key":"1144_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24649-w","volume":"12","author":"G Alvarado","year":"2021","unstructured":"Alvarado, G. et al. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat. Commun. 12, 4320 (2021).","journal-title":"Nat. Commun."},{"key":"1144_CR141","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.immuni.2019.05.007","volume":"50","author":"LC Lindesmith","year":"2019","unstructured":"Lindesmith, L. C. et al. Sera antibody repertoire analyses reveal mechanisms of broad and pandemic strain neutralizing responses after human norovirus vaccination. Immunity 50, 1530\u20131541 (2019).","journal-title":"Immunity"},{"key":"1144_CR142","doi-asserted-by":"publisher","first-page":"E5830","DOI":"10.1073\/pnas.1609990113","volume":"113","author":"S Shanker","year":"2016","unstructured":"Shanker, S. et al. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc. Natl Acad. Sci. USA 113, E5830\u2013E5837 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1144_CR143","doi-asserted-by":"publisher","first-page":"e00660-20","DOI":"10.1128\/JVI.00660-20","volume":"94","author":"AD Koromyslova","year":"2020","unstructured":"Koromyslova, A. D. et al. Nanobody-mediated neutralization reveals an Achilles heel for norovirus. J. Virol. 94, e00660-20 (2020).","journal-title":"J. Virol."},{"key":"1144_CR144","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1128\/JVI.03176-14","volume":"89","author":"AD Koromyslova","year":"2015","unstructured":"Koromyslova, A. D. & Hansman, G. S. Nanobody binding to a conserved epitope promotes norovirus particle disassembly. J. Virol. 89, 2718\u20132730 (2015).","journal-title":"J. Virol."},{"key":"1144_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005719","volume":"12","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G. et al. Frequent use of the IgA isotype in human B cells encoding potent norovirus-specific monoclonal antibodies that block HBGA binding. PLoS Pathog. 12, e1005719 (2016).","journal-title":"PLoS Pathog."},{"key":"1144_CR146","doi-asserted-by":"publisher","first-page":"e02174","DOI":"10.1128\/JVI.02174-18","volume":"93","author":"AD Koromyslova","year":"2019","unstructured":"Koromyslova, A. D., Morozov, V. A., Hefele, L. & Hansman, G. S. Human norovirus neutralized by a monoclonal antibody targeting the histo-blood group antigen pocket. J. Virol. 93, e02174-18 (2019).","journal-title":"J. Virol."},{"key":"1144_CR147","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/infdis\/jiw259","volume":"214","author":"RL Atmar","year":"2016","unstructured":"Atmar, R. L. et al. Rapid responses to 2 virus-like particle norovirus vaccine candidate formulations in healthy adults: a randomized controlled trial. J. Infect. Dis. 214, 845\u2013853 (2016).","journal-title":"J. Infect. Dis."},{"key":"1144_CR148","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","volume":"210","author":"JJ Treanor","year":"2014","unstructured":"Treanor, J. J. et al. A novel intramuscular bivalent norovirus VLP vaccine candidate \u2014 reactogenicity, safety and immunogenicity in a phase I trial in healthy adults. J. Infect. Dis. 210, 1763\u20131771 (2014).","journal-title":"J. Infect. Dis."},{"key":"1144_CR149","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/infdis\/jiy529","volume":"219","author":"RL Atmar","year":"2019","unstructured":"Atmar, R. L. et al. An exploratory study of the salivary immunoglobulin A responses to 1 dose of a norovirus virus-like particle candidate vaccine in healthy adults. J. Infect. Dis. 219, 410\u2013414 (2019).","journal-title":"J. Infect. Dis."},{"key":"1144_CR150","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/infdis\/jiu497","volume":"211","author":"DI Bernstein","year":"2015","unstructured":"Bernstein, D. I. et al. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J. Infect. Dis. 211, 870\u2013878 (2015).","journal-title":"J. Infect. Dis."},{"key":"1144_CR151","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1016\/j.vaccine.2020.07.069","volume":"38","author":"J Sherwood","year":"2020","unstructured":"Sherwood, J. et al. Efficacy of an intramuscular bivalent norovirus GI.1\/GII.4 virus-like particle vaccine candidate in healthy US adults. Vaccine 38, 6442\u20136449 (2020).","journal-title":"Vaccine"},{"key":"1144_CR152","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/v11050392","volume":"11","author":"J Haynes","year":"2019","unstructured":"Haynes, J. et al. In depth breadth analyses of human blockade responses to norovirus and response to vaccination. Viruses 11, 392 (2019).","journal-title":"Viruses"},{"key":"1144_CR153","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.vaccine.2022.04.089","volume":"40","author":"T Vesikari","year":"2022","unstructured":"Vesikari, T. et al. Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: a phase 2 randomized, double-blind study. Vaccine 40, 3588\u20133596 (2022).","journal-title":"Vaccine"},{"key":"1144_CR154","doi-asserted-by":"publisher","first-page":"2204787","DOI":"10.1080\/21645515.2023.2204787","volume":"19","author":"P Lopez","year":"2023","unstructured":"Lopez, P. et al. Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: a phase 2 randomized, double-blind trial. Hum. Vaccin. Immunother. 19, 2204787 (2023).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1144_CR155","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/ NCT05281094 (2024)."},{"key":"1144_CR156","doi-asserted-by":"publisher","first-page":"102374","DOI":"10.1016\/j.coi.2023.102374","volume":"84","author":"MR Braun","year":"2023","unstructured":"Braun, M. R., Flitter, B. A., Sun, W. & Tucker, S. N. An easy pill to swallow: oral recombinant vaccines for the 21st century. Curr. Opin. Immunol. 84, 102374 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"1144_CR157","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.braindev.2018.04.001","volume":"40","author":"BR Kim","year":"2018","unstructured":"Kim, B. R. et al. Incidence and characteristics of norovirus-associated benign convulsions with mild gastroenteritis, in comparison with rotavirus ones. Brain Dev. 40, 699\u2013706 (2018).","journal-title":"Brain Dev."},{"key":"1144_CR158","unstructured":"Vaxart. Vaxart announces topline data from the phase 2 challenge study of its monovalent norovirus vaccine candidate. Vaxart, Inc. https:\/\/investors.vaxart.com\/news-releases\/news-release-details\/vaxart-announces-topline-data-phase-2-challenge-study-its (6 September 2023)."},{"key":"1144_CR159","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","volume":"365","author":"RL Atmar","year":"2011","unstructured":"Atmar, R. L. et al. Norovirus vaccine against experimental human Norwalk Virus illness. N. Engl. J. Med. 365, 2178\u20132187 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1144_CR160","doi-asserted-by":"publisher","first-page":"1021500","DOI":"10.3389\/fimmu.2022.1021500","volume":"13","author":"I Leroux-Roels","year":"2022","unstructured":"Leroux-Roels, I. et al. A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine. Front. Immunol. 13, 1021500 (2022).","journal-title":"Front. Immunol."},{"key":"1144_CR161","doi-asserted-by":"publisher","first-page":"1188431","DOI":"10.3389\/fimmu.2023.1188431","volume":"14","author":"G Waerlop","year":"2023","unstructured":"Waerlop, G. et al. Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant. Front. Immunol. 14, 1188431 (2023).","journal-title":"Front. Immunol."},{"key":"1144_CR162","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05916326 (2023)."},{"key":"1144_CR163","doi-asserted-by":"publisher","first-page":"15974","DOI":"10.1074\/jbc.RA120.014855","volume":"295","author":"I Rimkute","year":"2020","unstructured":"Rimkute, I. et al. Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection. J. Biol. Chem. 295, 15974\u201315987 (2020).","journal-title":"J. Biol. Chem."},{"key":"1144_CR164","doi-asserted-by":"publisher","first-page":"cwae029","DOI":"10.1093\/glycob\/cwae029","volume":"34","author":"J Nilsson","year":"2024","unstructured":"Nilsson, J. et al. N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. Glycobiology 34, cwae029 (2024).","journal-title":"Glycobiology"},{"key":"1144_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005334","volume":"12","author":"S Ramani","year":"2016","unstructured":"Ramani, S., Estes, M. K. & Atmar, R. L. Correlates of protection against norovirus infection and disease-where are we now, where do we go? PLoS Pathog. 12, e1005334 (2016).","journal-title":"PLoS Pathog."},{"key":"1144_CR166","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI115152","volume":"87","author":"SM Matsui","year":"1991","unstructured":"Matsui, S. M. et al. The isolation and characterization of a Norwalk virus-specific cDNA. J. Clin. Invest. 87, 1456\u20131461 (1991).","journal-title":"J. Clin. Invest."},{"key":"1144_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00683-1","volume":"8","author":"L Su","year":"2023","unstructured":"Su, L. et al. Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. NPJ Vaccines 8, 87 (2023).","journal-title":"NPJ Vaccines"},{"key":"1144_CR168","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/infdis\/jiac085","volume":"226","author":"JJA van Kampen","year":"2022","unstructured":"van Kampen, J. J. A. et al. Clinical and In vitro evidence favoring immunoglobulin treatment of a chronic norovirus infection in a patient with common variable immunodeficiency. J. Infect. Dis. 226, 1781\u20131789 (2022).","journal-title":"J. Infect. Dis."},{"key":"1144_CR169","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01663-23","volume":"98","author":"T Hayashi","year":"2024","unstructured":"Hayashi, T., Kobayashi, S., Hirano, J. & Murakami, K. Human norovirus cultivation systems and their use in antiviral research. J. Virol. 98, e0166323 (2024).","journal-title":"J. Virol."},{"key":"1144_CR170","doi-asserted-by":"publisher","first-page":"e01479","DOI":"10.1128\/JVI.01479-18","volume":"93","author":"MA Viskovska","year":"2019","unstructured":"Viskovska, M. A. et al. GII.4 norovirus protease shows pH-sensitive proteolysis with a unique Arg-His pairing in the catalyticsite. J. Virol. 93, e01479-18 (2019).","journal-title":"J. Virol."},{"key":"1144_CR171","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/ETLS20190164","volume":"4","author":"RJ Wheeler","year":"2020","unstructured":"Wheeler, R. J. Therapeutics-how to treat phase separation-associated diseases. Emerg. Top. Life Sci. 4, 307\u2013318 (2020).","journal-title":"Emerg. Top. Life Sci."},{"key":"1144_CR172","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13578-023-01101-8","volume":"13","author":"Y Zou","year":"2023","unstructured":"Zou, Y. et al. New insights into the important roles of phase seperation in the targeted therapy of lung cancer. Cell Biosci. 13, 150 (2023).","journal-title":"Cell Biosci."},{"key":"1144_CR173","doi-asserted-by":"publisher","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","volume":"76","author":"PR Harrington","year":"2002","unstructured":"Harrington, P. R., Lindesmith, L., Yount, B., Moe, C. L. & Baric, R. S. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76, 12335\u201312343 (2002).","journal-title":"J. Virol."},{"key":"1144_CR174","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1128\/JVI.77.1.405-415.2003","volume":"77","author":"AM Hutson","year":"2003","unstructured":"Hutson, A. M., Atmar, R. L., Marcus, D. M. & Estes, M. K. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J. Virol. 77, 405\u2013415 (2003).","journal-title":"J. Virol."},{"key":"1144_CR175","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1128\/JVI.79.11.6714-6722.2005","volume":"79","author":"P Huang","year":"2005","unstructured":"Huang, P. et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79, 6714\u20136722 (2005).","journal-title":"J. Virol."},{"key":"1144_CR176","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1128\/JVI.00802-08","volume":"82","author":"H Shirato","year":"2008","unstructured":"Shirato, H. et al. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J. Virol. 82, 10756\u201310767 (2008).","journal-title":"J. Virol."},{"key":"1144_CR177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089071","volume":"9","author":"S Yazawa","year":"2014","unstructured":"Yazawa, S. et al. Blood group substances as potential therapeutic agents for the prevention and treatment of infection with noroviruses proving novel binding patterns in human tissues. PLoS ONE 9, e89071 (2014).","journal-title":"PLoS ONE"},{"key":"1144_CR178","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3201\/eid1601.090633","volume":"16","author":"J Nordgren","year":"2010","unstructured":"Nordgren, J., Kindberg, E., Lindgren, P. E., Matussek, A. & Svensson, L. Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg. Infect. Dis. 16, 81\u201387 (2010).","journal-title":"Emerg. Infect. Dis."},{"key":"1144_CR179","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/v12090989","volume":"12","author":"ML Mallory","year":"2020","unstructured":"Mallory, M. L., Lindesmith, L. C., Brewer-Jensen, P. D., Graham, R. L. & Baric, R. S. Bile facilitates human norovirus interactions with diverse histoblood group antigens, compensating for capsid microvariation observed in 2016\u20132017 GII.2 strains. Viruses 12, 989 (2020).","journal-title":"Viruses"},{"key":"1144_CR180","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1128\/JVI.79.5.2900-2909.2005","volume":"79","author":"L Lindesmith","year":"2005","unstructured":"Lindesmith, L. et al. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79, 2900\u20132909 (2005).","journal-title":"J. Virol."},{"key":"1144_CR181","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcmgh.2020.03.006","volume":"10","author":"LC Lindesmith","year":"2020","unstructured":"Lindesmith, L. C. et al. Virus-host interactions between nonsecretors and human norovirus. Cell Mol. Gastroenterol. Hepatol. 10, 245\u2013267 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1144_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058605","volume":"8","author":"M Jin","year":"2013","unstructured":"Jin, M. et al. Two gastroenteritis outbreaks caused by GII noroviruses: host susceptibility and HBGA phenotypes. PLoS ONE 8, e58605 (2013).","journal-title":"PLoS ONE"},{"key":"1144_CR183","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1099\/jmm.0.000178","volume":"64","author":"T Yoda","year":"2015","unstructured":"Yoda, T. et al. No crucial amino acid changes in the predicted histo blood group antigen-binding sites of norovirus genotype GII.4 capsid between non-secretors and secretors origin might suggest an alternative route of infection or existence of coincidental molecules. J. Med. Microbiol. 64, 1544\u20131547 (2015).","journal-title":"J. Med. Microbiol."},{"key":"1144_CR184","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/infdis\/jis514","volume":"206","author":"R Frenck","year":"2012","unstructured":"Frenck, R. et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J. Infect. Dis. 206, 1386\u20131393 (2012).","journal-title":"J. Infect. Dis."},{"key":"1144_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005593","volume":"4","author":"B Carlsson","year":"2009","unstructured":"Carlsson, B. et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS ONE 4, e5593 (2009).","journal-title":"PLoS ONE"},{"key":"1144_CR186","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/cid\/civ165","volume":"60","author":"RL Currier","year":"2015","unstructured":"Currier, R. L. et al. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population. Clin. Infect. Dis. 60, 1631\u20131638 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1144_CR187","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.micinf.2014.02.010","volume":"16","author":"H Uusi-Kerttula","year":"2014","unstructured":"Uusi-Kerttula, H., Tamminen, K., Malm, M., Vesikari, T. & Blazevic, V. Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays. Microbes Infect. 16, 472\u2013480 (2014).","journal-title":"Microbes Infect."},{"key":"1144_CR188","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/INF.0000000000001446","volume":"36","author":"LT Tu","year":"2017","unstructured":"Tu, L. T. et al. Genetic susceptibility to norovirus GII.4 Sydney strain infections in Taiwanese children. Pediatr. Infect. Dis. J. 36, 353\u2013357 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1144_CR189","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.virs.2022.09.010","volume":"38","author":"X Cong","year":"2023","unstructured":"Cong, X. et al. Functional and structural characterization of norovirus GII.6 in recognizing histo-blood group antigens. Virol. Sin. 38, 56\u201365 (2023).","journal-title":"Virol. Sin."},{"key":"1144_CR190","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12560-019-09410-3","volume":"12","author":"S Sharma","year":"2020","unstructured":"Sharma, S. et al. Secretor status is associated with susceptibility to disease in a large GII.6 norovirus foodborne outbreak. Food Environ. Virol. 12, 28\u201334 (2020).","journal-title":"Food Environ. Virol."},{"key":"1144_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/srep17687","volume":"5","author":"XF Zhang","year":"2015","unstructured":"Zhang, X. F. et al. An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility. Sci. Rep. 5, 17687 (2015).","journal-title":"Sci. Rep."},{"key":"1144_CR192","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1128\/JCM.00865-17","volume":"55","author":"YC Dai","year":"2017","unstructured":"Dai, Y. C. et al. Characterization of antigenic relatedness between GII.4 and GII.17 noroviruses by use of serum samples from norovirus-infected patients. J. Clin. Microbiol. 55, 3366\u20133373 (2017).","journal-title":"J. Clin. Microbiol."},{"key":"1144_CR193","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04563533 (2024)."},{"key":"1144_CR194","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06524947 (2024)."},{"key":"1144_CR195","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05805618 (2023)."},{"key":"1144_CR196","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01168401 (2018)."},{"key":"1144_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001807","volume":"12","author":"LC Lindesmith","year":"2015","unstructured":"Lindesmith, L. C. et al. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial. PLoS Med. 12, e1001807 (2015).","journal-title":"PLoS Med."},{"key":"1144_CR198","doi-asserted-by":"publisher","first-page":"e00571","DOI":"10.1128\/CVI.00571-16","volume":"24","author":"S Ramani","year":"2017","unstructured":"Ramani, S. et al. B-cell responses to intramuscular administration of a bivalent virus-like particle human norovirus vaccine. Clin. Vaccin. Immunol. 24, e00571-16 (2017).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1144_CR199","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01609257 (2019)."},{"key":"1144_CR200","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1128\/CVI.00196-15","volume":"22","author":"RL Atmar","year":"2015","unstructured":"Atmar, R. L. et al. Serological correlates of protection against a GII.4 norovirus. Clin. Vaccin. Immunol. 22, 923\u2013929 (2015).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1144_CR201","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.vaccine.2014.09.073","volume":"33","author":"A Sundararajan","year":"2015","unstructured":"Sundararajan, A. et al. Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine. Vaccine 33, 568\u2013576 (2015).","journal-title":"Vaccine"},{"key":"1144_CR202","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02038907 (2017)."},{"key":"1144_CR203","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/infdis\/jix572","volume":"217","author":"G Leroux-Roels","year":"2018","unstructured":"Leroux-Roels, G. et al. Safety and immunogenicity of different formulations of norovirus vaccine candidate in healthy adults: a randomized, controlled, double-blind clinical trial. J. Infect. Dis. 217, 597\u2013607 (2018).","journal-title":"J. Infect. Dis."},{"key":"1144_CR204","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02142504 (2017)."},{"key":"1144_CR205","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/infdis\/jiz170","volume":"220","author":"RL Atmar","year":"2019","unstructured":"Atmar, R. L. et al. Persistence of antibodies to 2 virus-like particle norovirus vaccine candidate formulations in healthy adults: 1-year follow-up with memory probe vaccination. J. Infect. Dis. 220, 603\u2013614 (2019).","journal-title":"J. Infect. Dis."},{"key":"1144_CR206","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02153112 (2019)."},{"key":"1144_CR207","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02475278 (2018)."},{"key":"1144_CR208","first-page":"739","volume":"221","author":"RL Atmar","year":"2020","unstructured":"Atmar, R. L. et al. Comparison of microneutralization and histo-blood group antigen-blocking assays for functional norovirus antibody detection. J. Infect. Dis. 221, 739\u2013743 (2020).","journal-title":"J. Infect. Dis."},{"key":"1144_CR209","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02661490 (2020)."},{"key":"1144_CR210","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02669121 (2021)."},{"key":"1144_CR211","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/infdis\/jiad401","volume":"229","author":"RL Atmar","year":"2024","unstructured":"Atmar, R. L. et al. A bivalent human norovirus vaccine induces homotypic and heterotypic neutralizing antibodies. J. Infect. Dis. 229, 1402\u20131407 (2024).","journal-title":"J. Infect. Dis."},{"key":"1144_CR212","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03039790 (2022)."},{"key":"1144_CR213","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05972733 (2024)."},{"key":"1144_CR214","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06007781 (2023)."},{"key":"1144_CR215","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05508178 (2022)."},{"key":"1144_CR216","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05992935 (2024)."},{"key":"1144_CR217","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06592794 (2024)."},{"key":"1144_CR218","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04188691 (2021)."},{"key":"1144_CR219","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04941261 (2021)."},{"key":"1144_CR220","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05916326 (2021)."},{"key":"1144_CR221","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02868073 (2018)."},{"key":"1144_CR222","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121077","volume":"3","author":"L Kim","year":"2018","unstructured":"Kim, L. et al. Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial. JCI Insight 3, e121077 (2018).","journal-title":"JCI Insight"},{"key":"1144_CR223","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03125473 (2018)."},{"key":"1144_CR224","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03897309 (2022)."},{"key":"1144_CR225","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04854746 (2023)."},{"key":"1144_CR226","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04875676 (2024)."},{"key":"1144_CR227","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05212168 (2024)."},{"key":"1144_CR228","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05213728 (2024)."},{"key":"1144_CR229","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05626803 (2024)."},{"key":"1144_CR230","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1128\/JVI.00674-07","volume":"81","author":"JJ Siebenga","year":"2007","unstructured":"Siebenga, J. J. et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol. 81, 9932\u20139941 (2007).","journal-title":"J. Virol."},{"key":"1144_CR231","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/v13020155","volume":"13","author":"JCM Chan","year":"2021","unstructured":"Chan, J. C. M., Mohammad, K. N., Zhang, L. Y., Wong, S. H. & Chan, M. C. Targeted profiling of immunological genes during norovirus replication in human intestinal enteroids. Viruses 13, 155 (2021).","journal-title":"Viruses"},{"key":"1144_CR232","first-page":"3365","volume":"11","author":"L Lin","year":"2019","unstructured":"Lin, L. et al. Replication and transcriptionomic analysis of human noroviruses in human intestinal enteroids. Am. J. Transl. Res. 11, 3365\u20133374 (2019).","journal-title":"Am. J. Transl. Res."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-024-01144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-024-01144-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-024-01144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:03:33Z","timestamp":1747641813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-024-01144-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":232,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1038\/s41579-024-01144-9","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"12 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.L.A., M.K.E. and B.V.V.P. have grant support from Hillevax, Inc., and R.L.A. and M.K.E. are consultants for that company. Baylor College of Medicine (R.L.A. and M.K.E. as inventors) has a patent for norovirus growth in human intestinal enteroids. M.K.E. has a patent on methods and reagents to detect and characterize Norwalk virus and related viruses. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}